Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 8, 2015, Pages 1472-1479

  Wong, Martin C S ^a   Ching, Jessica Y L ^a   Chan, Victor C W ^a   Lam, Thomas Y T ^a   Shum, Jeffrey P ^a   Luk, Arthur K C ^a   Wong, Sunny S H ^a   Ng, Siew C ^a   Ng, Simon S M ^a   Wu, Justin C Y ^a   Chan, Francis K L ^a   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Colorectal cancer screening; Sensitivity; Specificity; Specimen number

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ANATOMICAL VARIATION; ARTICLE; ASCENDING COLON; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER SCREENING; CANCER SIZE; CHINESE; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; DESCENDING COLON; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PREDICTIVE VALUE; QUALITATIVE FECAL IMMUNOCHEMICAL TEST; SENSITIVITY AND SPECIFICITY; CHEMISTRY; COLON; COLORECTAL NEOPLASMS; DIAGNOSTIC TEST; EVALUATION STUDY; FECES; HONG KONG; IMMUNOASSAY; LABORATORY TEST; MASS SCREENING; MIDDLE AGED; PATHOLOGY; PROCEDURES;

HEMOGLOBIN;

AGED; CLINICAL LABORATORY TECHNIQUES; COLON; COLORECTAL NEOPLASMS; DIAGNOSTIC TESTS, ROUTINE; FECES; FEMALE; HEMOGLOBINS; HONG KONG; HUMANS; IMMUNOASSAY; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84937517538     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.02.021     Document Type: Article

References (30)

1. Ferlay J., Shin H.R., Bray F., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
2. Rex D.K., Johnson D.A., Anderson J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009, 104:739-750.
3. Levin B., Lieberman D.A., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008, 134:1570-1595.
4. Sung J.J., Ng S.C., Chan F.K., et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 2015, 64:121-132.
5. Rabeneck L., Rumble R.B., Thompson F., et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol 2012, 26:131-147.
6. Whitlock E.P., Lin J.S., Liles E., et al. Screening for colorectal cancer: a targeted, updated systematic review for the US Preventive Services Task Force. Ann Intern Med 2008, 149:638-658.
7. Chen L.S., Yen A.M., Chiu S.Y., et al. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncol 2011, 12:551-558.
8. Stegeman I., de Wijkerslooth T.R., Mallant-Hent R.C., et al. Implementation of population screening for colorectal cancer by repeated fecal immunochemical test (FIT): third round. BMC Gastroenterol 2012, 12:73.
9. Steele R.J., McDonald P.J., Digby J., et al. Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity. United European Gastroenterol J 2013, 1:198-205.
10. Morikawa T., Kato J., Yamaji Y., et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005, 129:422-428.
11. Haug U., Hundt S., Brenner H. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia. Br J Cancer 2011, 104:1779-1785.
12. de Wijkerslooth T.R., de Haan M.C., Stoop E.M., et al. Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography-a randomized controlled trial. BMC Gastroenterol 2010, 10:47.
13. de Wijkerslooth T.R., Stoop E.M., Bossuyt P.M., et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 2012, 107:1570-1578.
14. Soon M.S., Kozarek R.A., Ayub K., et al. Screening colonoscopy in Chinese and Western patients: a comparative study. Am J Gastroenterol 2005, 100:2749-2755.
15. Byeon J.S., Yang S.K., Kim T.I.I., et al. Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointest Endosc 2007, 65:1015-1022.
16. Lee J.K., Liles E.G., Bent S., et al. Accuracy of fecal immunochemical tests for colorectal cancer. Ann Intern Med 2014, 160:171-181.
17. Nakama H., Yamamoto M., Kamijo N., et al. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology 1999, 46:228-231.
18. Park D.I., Ryu S., Kim Y.H., et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010, 105:2017-2025.
19. Ng S.C., Ching J.Y.L., Chan V.C.W., et al. Diagnostic accuracy of fecal immunochemical test for screening individuals with a family history of colorectal cancer. Aliment Pharmacol Ther 2013, 38:835-841.
20. Wong M.C., Ching J.Y., Lam T.Y., et al. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong. Prev Med 2013, 57:227-231.
21. STARD statement. Available at: . Accessed February 1, 2015. http://www.stard-statement.org/.
22. Fraser C.G., Allison J.E., Halloran S.P., et al. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst 2012, 104:810-814.
23. Rex D.K., Petrini J.L., Baron T.H., et al. Quality indicators for colonoscopy. Gastrointest Endosc 2006, 63. S16-S28.
24. Imperiale T.F., Wagner D.R., Lin C.Y., et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 2002, 346:1781-1785.
25. Wong M.C., Ching J.C., Chan V.C., et al. Factors associated with false positive and false negative faecal immunochemical test results for colorectal cancer screening. Gastrointest Endosc 2015, 81:596-607.
26. Chubak J., Bogart A., Fuller S., et al. Uptake and positive predictive value of fecal occult blood tests: a randomized controlled trial. Prev Med 2013, 57:671-678.
27. van Roon A.H., Wilschut J.A., Hol L., et al. Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol 2011, 9:333-339.
28. Steele R.J., McClements P., Watling C., et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 2012, 61:576-581.
29. Rex D.K., Petrini J.L., Baron T.H., et al. Quality indicators for colonoscopy. Am J Gastroenterol 2006, 101:873-885.
30. van Rijn J.C., Reitsma J.B., Stoker J., et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006, 101:343-350.